DLD Asset Management’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-80,000
Closed -$5.43M 116
2019
Q3
$5.43M Buy
+80,000
New +$5.49M 0.27% 32

DLD Asset Management's GHDX Position: Q4 2019 in Review

DLD Asset Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 80,000 shares — an estimated $5.43M sold.

DLD Asset Management first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $5.43M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

  • DLD Asset Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
  • DLD Asset Management sold 80,000 Genomic Health, Inc. shares in Q4 2019, an estimated $5.43M.
  • DLD Asset Management first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
  • DLD Asset Management's Genomic Health, Inc. position peaked at $5.43M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on DLD Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.